Virtual Screening and Validation of Affinity DNA Functional Ligands for IgG Fc Segment.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
09 Aug 2024
Historique:
received: 04 07 2024
revised: 05 08 2024
accepted: 07 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

The effective attachment of antibodies to the immune sensing interface is a crucial factor that determines the detection performance of immunosensors. Therefore, this study aims to investigate a novel antibody immobilization material with low molecular weight, high stability, and excellent directional immobilization effect. In this study, we employed molecular docking technology based on the ZDOCK algorithm to virtually screen DNA functional ligands (DNAFL) for the Fc segment of antibodies. Through a comprehensive analysis of the key binding sites and contact propensities at the interface between DNAFL and IgG antibody, we have gained valuable insights into the affinity relationship, as well as the principles governing amino acid and nucleotide interactions at this interface. Furthermore, molecular affinity experiments and competitive binding experiments were conducted to validate both the binding ability of DNAFL to IgG antibody and its actual binding site. Through affinity experiments using multi-base sequences, we identified bases that significantly influence antibody-DNAFL binding and successfully obtained DNAFL with an enhanced affinity towards the IgG Fc segment. These findings provide a theoretical foundation for the targeted design of higher-affinity DNAFLs while also presenting a new technical approach for immunosensor preparation with potential applications in biodetection.

Identifiants

pubmed: 39201368
pii: ijms25168681
doi: 10.3390/ijms25168681
pii:
doi:

Substances chimiques

Immunoglobulin G 0
Ligands 0
DNA 9007-49-2
Immunoglobulin Fc Fragments 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : State Key Laboratory of NBC Protection for Civilian
ID : SKLNBC2022-06

Auteurs

Qianyu Yang (Q)

State Key Laboratory of NBC Protection for Civilian, Beijing 102205, China.

Zhiwei Liu (Z)

State Key Laboratory of NBC Protection for Civilian, Beijing 102205, China.

Xinrui Xu (X)

State Key Laboratory of NBC Protection for Civilian, Beijing 102205, China.

Jiang Wang (J)

State Key Laboratory of NBC Protection for Civilian, Beijing 102205, China.

Bin Du (B)

State Key Laboratory of NBC Protection for Civilian, Beijing 102205, China.

Pengjie Zhang (P)

State Key Laboratory of NBC Protection for Civilian, Beijing 102205, China.

Bing Liu (B)

State Key Laboratory of NBC Protection for Civilian, Beijing 102205, China.

Xihui Mu (X)

State Key Laboratory of NBC Protection for Civilian, Beijing 102205, China.

Zhaoyang Tong (Z)

State Key Laboratory of NBC Protection for Civilian, Beijing 102205, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH